Suitability of infiltrative lobular breast carcinoma for anti-human epidermal growth factor receptor 2 treatment after the ASCO/CAP and 2009 St Gallen International Expert Consensus meeting.

Source:http://linkedlifedata.com/resource/pubmed/id/21166708

Download in:

View as

General Info

PMID
21166708